Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Leases (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Leases for 11 consecutive years, with $20000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Leases fell 81.13% to $20000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $20000.0, a 81.13% decrease, with the full-year FY2024 number at $73000.0, down 63.86% from a year prior.
  • Leases was $20000.0 for Q3 2025 at Plus Therapeutics, down from $29000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $1.8 million in Q4 2022 to a low of $3000.0 in Q1 2021.
  • A 5-year average of $301444.4 and a median of $217000.0 in 2023 define the central range for Leases.
  • Peak YoY movement for Leases: plummeted 99.6% in 2021, then skyrocketed 10433.33% in 2022.
  • Plus Therapeutics' Leases stood at $559000.0 in 2021, then skyrocketed by 223.79% to $1.8 million in 2022, then crashed by 88.84% to $202000.0 in 2023, then crashed by 63.86% to $73000.0 in 2024, then plummeted by 72.6% to $20000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Leases are $20000.0 (Q3 2025), $29000.0 (Q2 2025), and $38000.0 (Q1 2025).